2.0
26 Mar 2026
Anonymous employee
Former employee, more than 3 years
Recommend
CEO approval
Business outlook
Pros
Intellectual horsepower of the talent, the speed, the mission, the Alphabet/tech ecosystem = all top tier
Cons
the lack of alchemy at the VLT, the clear gap and/or lack of prioritization of clinical/life sciences - betrays a signal for a real lack of awareness at the senior most levels. The product suite that just really don't make sense. It's like a Roche product ambition with none of the market penetration.